View Older Stories View More Recent Stories
-
Power Solutions International to Present at Upcoming Investor Conferences
-
Strong Volumes Help JinkoSolar (JKS) in Q1; Next Catalysts Include Power Spin, FIT Payments - Roth Capital
-
Roth Capital Reiterates Buy on Revolution Lighting (RVLT) Expecting a 2Q Rebound
-
Claims Administrator Angeion Group Announces Proposed Settlement In China-Biotics Class Action
-
Roth Capital Downgrades Rally Software (RALY) to Neutral on Takeover; Look at (CTCT) (LPSN) (TNGO) to Replace
-
NV5 Announces Closing of Underwritten Public Offering of Common Stock
-
Notable Analyst Rating Changes 5/28: (RL) (JCI) (GM) Upgraded; (BT) (BONT) (TFM) Downgraded
-
Pre-Open Stock Movers 05/28: (RALY) (BIOC) (EXPR) Higher; (NBS) (DANG) (TLYS) Lower (more...)
-
Roth Capital Starts Digital Ally (DGLY) at Buy
-
Hydrogenics' (HYGS) Agreement with Alstom Seen as 'Milestone' for Fuel Cell Industry by Roth Capital
-
Wave Announces Closing of Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares
-
Roth Affirms bluebird bio (BLUE) at 'Buy'; Getting More Aggressive in Immuno-Onocology Sans Celgene (CELG)
-
Roth Capital Lifts FY15 Gross Margin, EPS Outlooks on Sky Solar (SKYS) Following Q1 Results, Maintained Guidance
-
Unusual 11 Mid-Day Movers 5/26: (GKNT) (ATNM) (FXCM) Higher; (CYRN) (JMEI) (GMAN) Lower
-
Streetinsider.com's Hot Lunchtime Reads 5/22: (DGX) (AAPL) (AWR) (DE)
-
Roth Capital 'Encouraged' by Latest GALE-401 Phase 2 Data; Affirms 'Buy' Rating on Galena Biopharma (GALE)
-
Notable Analyst Rating Changes 5/22: (RWLK) (BAH) (DOV) Upgraded; (GD) (JGW) (CONN) Downgraded
-
NV5 Holdings (NVEE) Prices 1.43M Common Offering at $19.50/Share
-
NV5 Prices Underwritten Public Offering of Common Stock
-
Roth Capital Affirms Trina Solar (TSL) at 'Buy'; Q1 Results Show Core Strength of Manufacturing Business
-
Roth Capital Starts Vascular Biogenics Ltd (VBLT) at Buy
-
NV5 Announces Proposed Public Offering of Common Stock
-
Roth Affirms BlurBird (BLUE) at 'Buy'; Prelim. SCD Data at High-End of Expectations
-
WSJ Article Comparing Sarepta (SRPT) and BioMarin (BMRN) 'Juvenile and Uninformed', Roth Capital Says
-
Notable Analyst Rating Changes 5/21: (SSYS) (VOD) (CHTR) Upgraded; (WBAI) (SRPT) (JASO) Downgraded
-
Roth Lifts PT on Regeneron (REGN) to $495 Following Sarilumab Phase 3 Results in RA
-
Wave Systems (WAVX) Prices 7.3M Units Offering for Proceeds of $4.7M
-
Wave Announces Pricing of Public Offering
-
Roth Capital Starts Darling International (DAR) at Buy
-
Roth Capital Resumes Cempra, Inc. (CEMP) at Buy
-
Roth Capital Downgrades JA Solar Holdings Co., Ltd. (JASO) to Neutral
-
Wave Systems (WAVX) Announces Common, Warrants Offering
-
Wave Announces Public Offering
-
Ideal Power Inc. Announces Closing of Underwritten Public Offering of Common Stock
-
Sarepta Therapeutic (SRPT) PT Raised to $45 at Roth Capital
-
Interactive Intelligence Has Priced $150 Million in Convertible Senior Notes
-
bluebird bio (BLUE) PT Raised to $192 at Roth Capital
-
Roth Affirms BioBlast Pharma (ORPN) at 'Buy' Following Q1 Report; U.S. Phase II/III HOPEMD Enrollment Remains Next Milestone
-
Roth Capital Downgrades Radiant Logistics (RLGT) to Neutral
-
Roth Capital Reiterates Buy on Green Plains (GPRE) Following Green Plains Partners (GPP) Public Prospectus Release
-
Canadian Solar (CSIQ) PT Raised to $46 at Roth Capital Despite Disappointing Investor Day
-
Roth Affirms Regeneron (REGN) at 'Neutral'; Dupilumab Success in Asthma Largely Priced-in
-
Streetinsider.com's Hot Lunchtime Reads 5/18: (AAPL) (FB) (PLT) (ANIP)
-
ANI Pharmaceuticals (ANIP) PT Lowered to $60 at Roth Capital
-
Roth Remains Positive on Concert Pharma (CNCE) Amid Upcoming AVP-786 Phase 3s (AVNR)
-
Pre-Open Stock Movers 05/18: (ANN) (ASNA) (SGYP) Higher; (EBIO) (TSLA) (ENDP) Lower (more...)
-
Roth Capital Reiterates Buy Following Pioneer Power (PPSI) Q1 Results
-
Roth Capital Starts Biodel (BIOD) at Buy, $5 PT
-
Roth Capital Previews bluebird bio (BLUE) Ahead of EHA Abstract
-
Roth Capital Sees Compelling Opportunities Ahead for uniQure BV (QURE)

